Regulation & Compliance

A renewed alliance aims to break key supply chain bottlenecks in gene therapy, offering developers faster access to critical, regulatory-ready materials.

After private rejections, Dream Finders Homes takes its acquisition offer public, putting pressure on Beazer's board amid the rival's financial struggles.

As new rules threaten Medicaid for millions, a health coalition released a blueprint for using AI responsibly. But will states and tech vendors listen?

Amidst domestic housing fears, a major UK asset manager's financing of CMI Financial Group highlights global confidence and the growing power of private credit.

Actuate Therapeutics gets FDA nod for its oral cancer drug elraglusib, shifting strategy to improve patient outcomes and tackle hard-to-treat tumors.

The fintech giant's new report reveals a major shift, tying management pay to sustainability and deploying AI to empower small businesses globally.

A new search platform, AnySearch, aims to revolutionize AI by giving agents access to the high-value, hidden data that traditional search engines miss.

Mobupps has launched ECHO AI, a self-learning engine aiming to automate ad campaigns, lower costs, and challenge industry giants with real-time intelligence.

The Ohio State Bar Association sells its insurer, OBLIC, to national leader ALPS, promising enhanced resources for lawyers in a consolidating market.

Poston Communications unveils an agentic AI platform designed for legal marketing, promising immediate ROI, robust security, and a focus on industry compliance.

The former solar EV pioneer has completed its radical pivot, selling its solar business to management and betting its entire future on Bitcoin.

Strategic Value Partners acquires Birdsboro Power, a key asset for meeting soaring electricity demand driven by AI and data centers in the PJM grid.

Nuro secures a critical CPUC permit, joining an exclusive group of AV companies in California and accelerating its plan to launch a robotaxi service with Uber.

Butterfly Network adds B. Braun veteran Caroll Neubauer to its board, a strategic move to leverage his global scaling and policy expertise for growth.

The Ethical AI Governance Group expands to Europe, appointing new leadership and forging global alliances to move AI from experimentation to responsible adoption.

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.

The Brownie Baker recalls mislabeled muffins with undeclared walnuts, highlighting the life-threatening risks of packaging mistakes in the food industry.

The firm reported a 3.7% drop in net asset value and a net loss for Q1 2026, raising questions about its dividend sustainability despite a stable payout.

On Red Dress Day, Métis leaders passed a sacred trust to PM Carney, demanding an end to funding gaps and real action on the stalled MMIWG2S+ crisis.

Facing financial pressures, the biotech divests a key cancer program, repays debt, and now explores all options to maximize value for its remaining pipeline.